BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

21 related articles for article (PubMed ID: 37416139)

  • 1. Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies.
    BioMed Research International
    Biomed Res Int; 2016; 2016():2514067. PubMed ID: 27127781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retracted: Studying the Role and Molecular Mechanisms of
    International BR
    Biomed Res Int; 2024; 2024():9760191. PubMed ID: 38550169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retracted: Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9808126. PubMed ID: 38550199
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: Establishment and Validation of an MTORC1 Signaling-Related Gene Signature to Predict Overall Survival in Patients with Hepatocellular Carcinoma.
    International BR
    Biomed Res Int; 2024; 2024():9851737. PubMed ID: 38549990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Retracted] HCV‑E2 inhibits hepatocellular carcinoma metastasis by stimulating mast cells to secrete exosomal shuttle microRNAs.
    Xiong L; Zhen S; Yu Q; Gong Z
    Oncol Lett; 2024 Jul; 28(1):301. PubMed ID: 38765790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retracted: Discovering Common Pathophysiological Processes between COVID-19 and Cystic Fibrosis by Differential Gene Expression Pattern Analysis.
    International BR
    Biomed Res Int; 2024; 2024():9789856. PubMed ID: 38550179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis.
    Methods In Medicine CAM
    Comput Math Methods Med; 2023; 2023():9829281. PubMed ID: 37416139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research.
    International BR
    Biomed Res Int; 2023; 2023():9850584. PubMed ID: 37475788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: Prognostic Value of Stem Cell Index-Related Characteristics in Primary Hepatocellular Carcinoma.
    Imaging CMM
    Contrast Media Mol Imaging; 2023; 2023():9850917. PubMed ID: 37502512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retracted: The Value of Color Doppler Ultrasound and CT Combined with Serum AFP Examination in the Diagnosis of Hepatocellular Carcinoma.
    Healthcare Engineering JO
    J Healthc Eng; 2023; 2023():9898507. PubMed ID: 37502098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: Prognostic Value of MUC16 Mutation and Its Correlation with Immunity in Hepatocellular Carcinoma Patients.
    And Alternative Medicine EC
    Evid Based Complement Alternat Med; 2023; 2023():9754067. PubMed ID: 37501844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis.
    Yu J; Gao G; Wang J; Zhao J; Zhang Y; Jiang D; Huang F
    Comput Math Methods Med; 2022; 2022():4835417. PubMed ID: 35651922
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.